Recent Insider Transactions - Prelude Therapeutics (NASDAQ: PRLD)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ PRLD Prelude Therapeutics

Huang Jane / officer: President, CMO

01/04/2025

Sell

$1.39

3,859

$5K

68,857

NASDAQ PRLD Prelude Therapeutics

Vaddi Krishna / director, officer: CEO

12/31/2024

Buy

$1.21

5,000

$6K

142,553

NASDAQ PRLD Prelude Therapeutics

Vaddi Krishna / director, officer: CEO

12/30/2024

Buy

$1.20

10,000

$12K

137,553

NASDAQ PRLD Prelude Therapeutics

Combs Andrew / officer: Chief Chemistry Officer

12/23/2024

Buy

$1.37

60,000

$82K

377,623

NASDAQ PRLD Prelude Therapeutics

Combs Andrew / officer: Chief Chemistry Officer

12/20/2024

Buy

$1.15

3,075

$4K

317,623

NASDAQ PRLD Prelude Therapeutics

Lim Bryant David / officer: CLO, Interim CFO, Corp Sec.

12/19/2024

Buy

$0.91

25,000

$23K

27,400

NASDAQ PRLD Prelude Therapeutics

Vaddi Krishna / director, officer: CEO

12/18/2024

Buy

$0.93

100,000

$93K

1.17M

NASDAQ PRLD Prelude Therapeutics

Vaddi Krishna / director, officer: CEO

12/19/2024

Buy

$0.89

6,888

$6K

127,553